WELL:PA:PA-HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF - Accumulating EUR (EUR)

ETF | Others |

Last Closing

USD 6.3502

Change

-0.03 (-0.49)%

Market Cap

N/A

Volume

106.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.48 (-1.06%)

USD 63.50B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-0.60 (-0.11%)

USD 12.35B
WRD:PA HSBC ETFs Public Limited Compa..

-0.03 (-0.09%)

USD 10.45B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-1.21 (-0.51%)

USD 8.60B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-0.90 (-0.19%)

USD 8.46B
WLD:PA Lyxor UCITS MSCI World D-EUR

-0.48 (-0.14%)

USD 7.00B
HHH:PA HSBC ETFs Public Limited Compa..

-0.12 (-0.21%)

USD 6.90B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.04 (-0.20%)

USD 6.43B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-0.40 (-0.10%)

USD 5.51B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

-0.14 (-0.08%)

USD 4.88B

ETFs Containing WELL:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.06% 10% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.06% 10% F 39% F
Trailing 12 Months  
Capital Gain 6.14% 27% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.14% 25% F 50% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.92% 14% F 29% F
Dividend Return -0.92% 13% F 27% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.74% 87% B+ 93% A
Risk Adjusted Return -15.95% 17% F 25% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.